Schroder Investment Management Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-7,719
| Closed | -$370K | – | 1401 |
|
|
2020
Q2 | $370K | Sell |
7,719
-237,778
| -97% | -$11.4M | ﹤0.01% | 1033 |
|
|
2020
Q1 | $11.6M | Buy |
245,497
+197,592
| +412% | +$9.35M | 0.02% | 510 |
|
|
2019
Q4 | $2.88M | Buy |
+47,905
| New | +$2.88M | ﹤0.01% | 825 |
|
|
2017
Q4 | – | Sell |
-3,728
| Closed | -$219K | – | 1393 |
|
|
2017
Q3 | $219K | Buy |
+3,728
| New | +$219K | ﹤0.01% | 1182 |
|